Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL21P73 (Ribosomal protein L21 pseudogene 73) is a processed pseudogene in the human genome that shares sequence similarity with the functional gene RPL21, which encodes a component of the 60S ribosomal subunit. Unlike its protein-coding counterpart, RPL21P73 does not produce a functional protein and currently has no known roles in normal physiology or disease. Essentially, RPL21P73 is not a protein, receptor, or therapeutic target, but a non-functional DNA sequence related to the ribosomal protein L21 gene. If you require information on the functional ribosomal protein L21 (RPL21)—a component of the large ribosomal subunit involved in protein synthesis and associated with certain hereditary hair loss syndromes—consider specifying "Ribosomal protein L21" or "RPL21" instead.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L21 pseudogene 73 (RPL21P73).